Skip to main content
. 2021 Jun;62(3):215–226. doi: 10.3325/cmj.2021.62.215

Table 2.

Relative expression of superoxide dismutase isoforms (Cu/Zn Sod, Mn Sod, and EC Sod), glutathione peroxidase 1 and 4 (Gpx1, Gpx4), and catalase (Cat) genes in female aortas. Data are presented as arithmetic mean ± SD (two-way ANOVA)

Female aortas Cu/Zn Sod* MnSod EC-Sod Gpx1§ Gpx4‖‖ Cat
Control
0.99 ± 0.63 (N = 4)
0.09 ± 0.36 (N = 5)
0.23 ± 0.25 (N = 5)
0.09 ± 0.05 (N = 5)
0.19 ± 0.20 (N = 5)
1.01 ± 0.79†† (N = 5)
Carbohydrate- and fat-rich diet (HSHFD)
0.61 ± 0.33 (N = 6)
0.09 ± 0.08 (N = 7)
0.15 ± 0.08 (N = 6)
0.08 ± 0.04 (N = 7)
0.19 ± 0.11 (N = 7)
0.84 ± 0.50†† (N = 5)
HSHFD+metformin
0.55 ± 0.64**(N = 6)
0.07 ± 0.06 (N = 5)
0.15 ± 0.23 (N = 6)
0.08 ± 0.07 (N = 6)
0.04 ± 0.02 (N = 6)
1.12 ± 0.90†† (N = 7)
HSHFD+liraglutide 1.48 ± 0.33** (N = 4) 0.30 ± 0.20 (N = 4) 0.70 ± 0.55 (N = 4) 0.24 ± 0.18 (N = 4) 0.14 ± 0.10 (N = 5) 13.99 ± 2.92 (N = 4)

*Cu/Zn Sod (P = 0.1026, F = 2.22).

MnSod (P = 0.7179, F = 0.4513).

EC-Sod (P = 0.2289, F = 1.512).

§Gpx1 (P = 0.2512, F = 1.426).

‖‖Gpx4 (P = 0.5166, F = 0.7716).

Cat (P < 0.0001, F = 78.42).

**HSHFD+liraglutide vs HSHFD; HSHFD+metformin (Cu/Zn Sod P < 0.05), Bonferroni post hoc test, P < 0.05.

††HSHFD+liraglutide vs HSHFD; HSHFD+metformin; control (Cat P < 0.05), Bonferroni post hoc test, P < 0.05.